Syn2bio S.A. (WSE:S2B)

Poland flag Poland · Delayed Price · Currency is PLN
33.20
+0.20 (0.61%)
Last updated: May 21, 2026, 2:06 PM CET
Market Cap288.06M
Revenuen/a
Net Incomen/a
EPSn/a
Shares Out8.73M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume20,446
Average Volume95,898
Open33.00
Previous Close33.00
Day's Range32.98 - 33.50
52-Week Range26.20 - 47.40
Betan/a
RSI49.13
Earnings DateJun 25, 2026

About Syn2bio

Syn2bio S.A., a biotechnology company, engages in the research and commercialization of Cardiac Marker, a radiopharmaceutical for diagnostic testing of heart disease in the field of myocardial perfusion. The company’s flagship project is the cardiotracer project, a radiopharmaceutical designed for testing myocardial perfusion and diagnosis of coronary artery disease. Additionally, it operates The Centre for Research on New Compounds, a unit engaged in the search for new pharmaceutical compounds and their further study, registration, and market ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2025
Country Poland
Stock Exchange Warsaw Stock Exchange
Ticker Symbol S2B
Full Company Profile